Biotage AB
STO:BIOT

Watchlist Manager
Biotage AB Logo
Biotage AB
STO:BIOT
Watchlist
Price: 160.8 SEK -1.65% Market Closed
Market Cap: 12.8B SEK
Have any thoughts about
Biotage AB?
Write Note

Biotage AB
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biotage AB
Cash from Operating Activities Peer Comparison

Comparables:
ALIF B
BICO
G
GENO
MCAP
M
MAGLE

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Biotage AB
STO:BIOT
Cash from Operating Activities
kr406m
CAGR 3-Years
6%
CAGR 5-Years
17%
CAGR 10-Years
19%
AddLife AB
STO:ALIF B
Cash from Operating Activities
kr773m
CAGR 3-Years
-7%
CAGR 5-Years
34%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Cash from Operating Activities
kr178.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genovis AB
STO:GENO
Cash from Operating Activities
kr37.3m
CAGR 3-Years
73%
CAGR 5-Years
60%
CAGR 10-Years
N/A
MedCap AB (publ)
STO:MCAP
Cash from Operating Activities
kr308.3m
CAGR 3-Years
41%
CAGR 5-Years
29%
CAGR 10-Years
28%
M
Magle Chemoswed Holding AB
STO:MAGLE
Cash from Operating Activities
kr15.3m
CAGR 3-Years
N/A
CAGR 5-Years
7%
CAGR 10-Years
N/A

See Also

What is Biotage AB's Cash from Operating Activities?
Cash from Operating Activities
406m SEK

Based on the financial report for Sep 30, 2024, Biotage AB's Cash from Operating Activities amounts to 406m SEK.

What is Biotage AB's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
19%

Over the last year, the Cash from Operating Activities growth was 77%. The average annual Cash from Operating Activities growth rates for Biotage AB have been 6% over the past three years , 17% over the past five years , and 19% over the past ten years .

Back to Top